Advised on the University’s role acting as a local sponsor for a phase II clinical trial. Our advice made recommendations on the contractual, structural and regulatory arrangements that should be put in place to manage risk and achieve compliance. We also reviewed and advised on amendments to draft contractual documentation provided by the overseas sponsor, including with respect to the ownership and licensing of intellectual property rights produced during the clinical trial.

This publication is introductory in nature. Its content is current at the date of publication. It does not constitute legal advice and should not be relied upon as such. You should always obtain legal advice based on your specific circumstances before taking any action relating to matters covered by this publication. Some information may have been obtained from external sources, and we cannot guarantee the accuracy or currency of any such information.